Regulations.gov document
Determination of Regulatory Review Period for Purposes of Patent Extension; Xience Prime…
Notice · FDA-2012-E-1241 · posted Jun 10, 2014
Key facts
| Document ID | FDA-2012-E-1241-0008 |
|---|---|
| Title | Determination of Regulatory Review Period for Purposes of Patent Extension; Xience Prime Ll Everolimus Eluting Coronary Stent System |
| Document type | Notice |
| Subtype | General Notice |
| Agency | FDA |
| Docket | FDA-2012-E-1241 |
| Posted | Jun 10, 2014 |
| Federal Register citation | 79 FR 33199 |
| FR document number | 2014-13445 |
| Comment period opens | Jun 10, 2014 |
| Comments due | Aug 12, 2014 |
| Effective date | Jun 10, 2014 |
At a glance
- 1–9 Pages
- No Open for comment
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: